Navigation Links
Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain

e in diabetic neuropathic pain. We look forward to the continued development of Zenvia for these two important indications. As previously stated, the company plans on initiating a confirmatory clinical trial in IEED with a new, lower quinidine dose formulation later this year," he added.

Conference Call

The company has scheduled a conference call for today, Wednesday, April 18, 2007 at 10:30 AM ET. Keith Katkin, President and CEO of Avanir, and Randall Kaye, MD, Senior Vice President and Chief Medical Officer, will discuss the results of this Phase III study. The call-in number is (877) 558-3407 for domestic and (706) 679-1941 for international callers, and the conference ID number is 6342812.

If you cannot attend the live broadcast, a webcast will be available online until May 18, 2007 at www.avanir.com. A telephone replay is available until April 23, 2007 and can be accessed by dialing (800) 642-1687 domestic and (706) 645-9291 international, and entering the conference ID number 6342812.

About Diabetic Neuropathic Pain

Diabetic neuropathic pain, one of the most debilitating forms of pain, is caused by nerve damage that can result from diabetes. It is often described as burning, tingling, stabbing, or pins and needles in the feet, legs, hands or arms. An estimated 3.5 million people in the United States experience diabetic neuropathic pain according to the American Diabetes Association.

About the Study

In 2005 AVANIR initiated a randomized double-blind, placebo-controlled, phase III clinical trial testing two doses of Zenvia in patients with painful diabetic neuropathy to assess efficacy, and overall safety and tolerability. The study was conducted at 40 sites in the US and Israel and was fully enrolled with 379 patients randomized across the three treatment arms (45 mg dextromethorphan / 30 mg quinidine BID dose, 30 mg dextromethorphan / 30 mg quinidine BID dose and placebo). The protocol for the study was reviewed
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Avanir Pharmaceuticals Presents IEED Prevalence and Updated Zenvia Long-Term Safety Data at AAN Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies

Post Your Comments:
(Date:11/6/2009)..., NATICK, Mass., Nov. 6 ...announced that it has reached an agreement in prin...lated to product advisories issued by its Guidant ...ct sales occurred prior to Boston Scientific,s 200...had previously disclosed an investigation by the U...
(Date:11/6/2009)..., SAN DIEGO, Nov. 6 Arde...ogy company focused on the development of small-mo...cer and human immunodeficiency virus (HIV), today ...lts for the third quarter and nine months ended Se...om.com/cgi-bin/prnh/20091104/ARDEALOGO ) ,, "Si...
(Date:11/6/2009)..., ATLANTA, Nov. 6 GeoVa... or "the Company"), an Atlanta-based, biopharmaceu...es caused by HIV-1 (Human Immunodeficiency Virus) ...hird quarter 2009 financial results and provided a... President and Chief Executive Officer commented, ...
Breaking Medicine Technology:Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 4Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 5Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 7Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 8Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 9Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 10Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 11Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 12Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 13Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 14Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 15Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 16Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 17Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Orion Health Live at Harley Street Clinic 48029 1Orion Health Live at Harley Street Clinic 48029 2Orion Health Live at Harley Street Clinic 48029 3New Provisional Restorations In Dentistry DVD by Paul R Chalifoux DDS 48026 1New Provisional Restorations In Dentistry DVD by Paul R Chalifoux DDS 48026 2iPod Repair Site Eases Scam Worries with Unexpected Announcements 48023 1iPod Repair Site Eases Scam Worries with Unexpected Announcements 48023 2iPod Repair Site Eases Scam Worries with Unexpected Announcements 48023 3
(Date:11/7/2009)...Nov. 7, The American Me...jamin Rush Award for Citizenship and Community Ser...rom Chicago, IL. The award recognizes physicians w...all of duty to make an outstanding public service ...eceived the award today during the opening session...
(Date:11/7/2009)...Nov. 7 Calling this a "defining mo...the AMA President J. James Rohack, M.D., today add... all state and medical specialty societies at the ...ting, where health system reform will top the agen...prnh/20081209/AMALOGO ) ,, "Over the next 72 ...
(Date:11/7/2009)..."Faithful Catholics have a responsibility to vigor... the status quo." ,, WASHINGTON, Nov. 7 /PR...ident Judie Brown released the following statement...ort Speaker Nancy Pelosi,s Affordable Health Care ... preserving the status quo for abortion is voted u...
(Date:11/7/2009).... 7 Americans United for Life Action endorses a k...sworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amen...from going to abortion in health care reform. ,, A...O Dr. Charmaine Yoest said, "Americans United for ...-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendment ...
(Date:11/7/2009)...ck to stem a growing problem across the U.S. , ... half of students at four-year colleges do it regu...inking -- downing five or more alcoholic drinks at... alcohol as a drug," said Jenny Hwang, associate d...ter at Stony Brook University on Long Island, N.Y....
Breaking Medicine News(10 mins):Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2Health News:Americans United for Life Action Endorses a Vote for the Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendment and Sends Score Letter to House Members 2Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 2Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 3
...An English expert says that certain over-the-count...n increase the risk of miscarriage. The comme...e Nielsen and colleagues published in this week's ...esearchers used prescription //records to identify...
...According to a new study at the Duke University in...of dying from heart failure. The link between depr...shed and generally have a worse outcome. The...rom major depression. Patients who were not depres...
... Researchers have found that headache stimuli also...lways been a mystery as to why loss of appetite of...stance, cannot face food and it is often assumed t...l, in a study,// the changes in the brain when pai...
... Family History is an important risk factor for mo...tre researcher.Cancers that occur early in life ar...se diagnosed later. Rare thyroid and testic..., or of several relatively rare genes. The...
...To reduce your risk of bowel cancer, a single raw...s from Boston University. Garlic is best know...werful anti-cancer properties. A substance called...e fed varying levels of disulfide to rats and foun...
...Heart devices may go wrong sometimes.There has bee...ng devices that regulate the heart rhythm. Ma...defibrillator to keep their heart beating rhythimi... US have surveyed safety warnings on heart devices...
Other Medicine News:
Slide Files
Tissue-Tek® Lab Aid®
Slide/Cassette Filing System
Shandon Slide and Paraffin Block Cabinets
Medicine Products: